URGN · UroGen Pharma Ltd.
$43.62
-1.88 (-4.13%)
At close · Aug 28
Going-concern doubt
— cleared Aug 5, 2026
The latest filing states the doubt was alleviated.
“Based on our cash and cash equivalents and marketable securities as of June 30, 2026, together with management's cash flow projections, we believe we have sufficient cash and cash equivalents to fund our operations beyond one year from the issuance of our condensed consolidated financial statements appearing elsewhere in this Quarterly Report.”View the 10-Q filed Aug 5, 2026
Market Cap
$2.13B
Shares
48.88M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $4,310,624 |
| Jason Smith | General Counsel and Chief Compliance Officer | $1,198,618 |
| Mark Schoenberg | Chief Medical Officer | $1,170,640 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $4,149,858 |
| Don Kim | Former Chief Financial Officer | $1,364,222 |
| Jason Smith | General Counsel and Chief Compliance Officer | $1,275,464 |
| Chris Degnan | Chief Financial Officer | $1,053,789 |
| Mark Schoenberg | Chief Medical Officer | $878,885 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $4,639,589 |
| Jason Smith | General Counsel and Chief Compliance Officer | $1,508,179 |
| Mark Schoenberg | Chief Medical Officer | $1,360,550 |
| Don Kim | Former Chief Financial Officer | — |
| Chris Degnan | Chief Financial Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $1,870,560 |
| Jason Smith | General Counsel and Chief Compliance Officer | $926,121 |
| Don Kim | Chief Financial Officer | $738,016 |
| Mark Schoenberg | Chief Medical Officer | $599,610 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $4,212,666 |
| Jason Smith | General Counsel and Chief Compliance Officer | $1,058,671 |
| Mark Schoenberg | Chief Medical Officer | $1,024,138 |
| Molly Henderson | Former Chief Financial Officer | $904,759 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $2,466,667 |
| Jason Smith | General Counsel and Chief Compliance Officer | $1,615,273 |
| Molly Henderson | Former Chief Financial Officer | $1,362,230 |
| Peter Pfreundschuh | Chief Financial Officer | $1,163,956 |
| Mark Schoenberg | Chief Medical Officer | $948,458 |
| Stephen L. Mullennix | Chief Operating Officer | $906,376 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Elizabeth Barrett | Chief Executive Officer | $25,900,823 |
| Peter Pfreundschuh | Chief Financial Officer | $1,346,791 |
| Stephen L. Mullennix | Chief Operating Officer | $1,346,512 |
| Mark Schoenberg | Chief Medical Officer | $800,908 |
| Ron Bentsur | Former Chief Executive Officer | $8,138 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Ron Bentsur | Former Chief Executive Officer | $5,950,112 |
| Stephen L. Mullennix | Chief Operating Officer | $4,309,568 |
| Peter Pfreundschuh | Chief Financial Officer | $2,485,800 |
| Mark Schoenberg | Chief Medical Officer | $300,000 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Ron Bentsur | Former Chief Executive Officer | $1,972,339 |
| Mark Schoenberg | Chief Medical Officer | $1,054,124 |
Executive changes
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
167 filings
167 filers
Visit website
Investor relations